DSE, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:DSE, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C5564
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:航空・防衛
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

DSE, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

DSE, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

DSE, Inc. (DSE) designs, develops, manufactures and markets a wide range of precision metal components, assemblies and ordnance products. The company’s product portfolio consists of both low velocity and high velocity ammunition products. Its low velocity ammunition products include M781 Practice (Orange Dye), M433 High Explosive Dual Purpose (HEDP) and M992 Dummy Cartridge. The company also offers a comprehensive range of high velocity ammunition products including M385A1 Practice, M918 Practice (Flash-Bang) and M430 High Explosive Dual Purpose. It is currently one of the world’s prime contractors of the US Army for 40mm ammunition. DSE is headquartered in Tampa, Florida, the US.

Scope

- Detailed information on DSE, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting DSE, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of DSE, Inc. including a breakdown and examination of key business segments
- Intelligence on DSE, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about DSE, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of DSE, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess DSE, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on DSE, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
DSE, Inc.: Company Overview 6
DSE, Inc.: Overview and Key Facts 6
DSE, Inc.: Overview 6
DSE, Inc.: Key Facts 6
DSE, Inc.: Major Products and Services 7
DSE, Inc.: Company History 8
DSE, Inc.: Key Competitors 9
DSE, Inc.: Company Analysis 10
DSE, Inc.: Business Description 10
DSE, Inc.: SWOT Analysis 11
DSE, Inc.: SWOT Overview 11
DSE, Inc.: Strengths 11
DSE, Inc.: Weaknesses 11
DSE, Inc.: Opportunities 12
DSE, Inc.: Threats 12
Appendix 14
Contact Us 14
Methodology 14
About MarketLine 15

List of Tables
Table 1: DSE, Inc.: Key Facts
Table 2: DSE, Inc.: Company History
Table 3: DSE, Inc.: Key Competitors



★海外企業調査レポート[DSE, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Honeywell International Inc (HON):企業の財務・戦略的SWOT分析
    Honeywell International Inc (HON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Twenty-First Century Fox, Inc.:企業の戦略・SWOT・財務情報
    Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report Summary Twenty-First Century Fox, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Blueprint Medicines Corp (BPMC):医療機器:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Applied Genetic Technologies Corp (AGTC):企業の財務・戦略的SWOT分析
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that provides development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It offers products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • 3E sanv:企業の戦略的SWOT分析
    3E sanv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Long Chen Paper Co., Ltd.:企業の戦略・SWOT・財務情報
    Long Chen Paper Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Long Chen Paper Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Clydesdale Bank PLC:企業の戦略的SWOT分析
    Clydesdale Bank PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Vaxil Bio Ltd (VXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaxil Bio Ltd (Vaxil Bio), formerly Emerge Resources Corp, is a drug development company that develops immunotherapy platform. The company’s immunptherapy pipeline products include antigen specific immunotherapies, signal peptide specific antibodies and anti-infectives. It develops Vaxhit te …
  • Yonsei University:製薬・医療:M&Aディール及び事業提携情報
    Summary Yonsei University (Yonsei) is an educational service provider that offers training and research services. The university offers graduation programs in various areas such as applied statistics, architectural engineering, Asian studies, astronomy, atmospheric sciences, biochemistry, bio conver …
  • Wilmar International Limited:企業の戦略・SWOT・財務情報
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Support.com, Inc. (SPRT):企業の財務・戦略的SWOT分析
    Support.com, Inc. (SPRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Syntel Inc (SYNT):企業の財務・戦略的SWOT分析
    Syntel Inc (SYNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • John Menzies plc:戦略・SWOT・企業財務分析
    John Menzies plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SAS AB:企業の戦略・SWOT・財務分析
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Ecrins Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company provides products such as native and labeled tubulin, tubulin polymerization kit and monoclo …
  • Spur Corporation Limited:企業の戦略・SWOT・財務分析
    Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Spur Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Mitsui Chemicals, Inc.:企業の戦略・SWOT・財務情報
    Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Chemicals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Otonomy Inc (OTIC):製薬・医療:M&Aディール及び事業提携情報
    Summary Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear. The company’s Otiprio is the US FDA approved ciprofloxacin otic suspension indicated during tympanostomy tube placement surgery in pediatric patients. Its pipeline portfolio encompasses Otividex for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆